Antipyrine clearance in pneumonia

Area of Science:

• Pharmacology
• Hepatology
• Infectious Diseases

Background:

• Microsomal hepatic drug metabolism is crucial for drug detoxification.
• Pneumonia, an acute respiratory infection, can impact systemic physiological functions.
• Understanding drug metabolism during acute illness is vital for patient management.

Purpose of the Study:

• To investigate the impact of acute pneumonia on antipyrine clearance in adult patients.
• To assess the recovery of hepatic drug metabolism following resolution of pneumonia.

Main Methods:

• Antipyrine clearance was measured using a one-sample technique.
• The study included 14 adult patients diagnosed with acute fever and clinical pneumonia.
• Measurements were taken during the acute phase and during convalescence (14 and 28 days later).

Main Results:

• Mean antipyrine clearance during acute pneumonia was significantly reduced (31.4 +/- 7.6 ml/min).
• Clearance values increased substantially during convalescence (47.8 +/- 18.9 ml/min at 14 days and 49.2 +/- 15.0 ml/min at 28 days).
• The data indicate a temporary impairment of hepatic drug metabolism.

Conclusions:

• Pneumonia impairs microsomal hepatic drug metabolism in adults.
• Hepatic drug metabolism function recovers during the convalescent period after pneumonia.
• These findings highlight the systemic effects of pneumonia on drug processing.